title: Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?
authors.forename: W W
authors.initials: WW
authors.lastname: Yew
authors.forename: C F
authors.initials: CF
authors.lastname: Wong
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: P C
authors.initials: PC
authors.lastname: Wong
authors.forename: C H
authors.initials: CH
authors.lastname: Chau
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002969:Clavulanic Acids / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D000658:Amoxicillin